BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.1707
+0.0023 (1.40%)
Mar 13, 2026, 12:59 PM EDT - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $13.85 million as of March 13, 2026. Its market cap has decreased by -30.08% in one year.
Market Cap
13.85M
Enterprise Value
11.52M
1-Year Change
-30.08%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $13.85M, a decrease of -97.60%. That is a compound annual growth rate of -50.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 13.66M | -59.24% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 14.68M |
| Quoin Pharmaceuticals | 14.46M |
| Phio Pharmaceuticals | 14.29M |
| Jupiter Neurosciences | 14.09M |
| Curis | 13.83M |
| Traws Pharma | 13.82M |
| BioCardia | 13.48M |
| Kairos Pharma | 13.33M |